First National Trust Co. raised its position in shares of UnitedHealth Group Inc. (NYSE:UNH) by 28.4% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 13,884 shares of the healthcare conglomerate’s stock after buying an additional 3,072 shares during the period. First National Trust Co.’s holdings in UnitedHealth Group were worth $1,960,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. MCF Advisors LLC boosted its position in UnitedHealth Group by 312.9% in the first quarter. MCF Advisors LLC now owns 958 shares of the healthcare conglomerate’s stock worth $123,000 after buying an additional 726 shares during the last quarter. Benjamin F. Edwards & Company Inc. boosted its position in UnitedHealth Group by 91.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,082 shares of the healthcare conglomerate’s stock worth $153,000 after buying an additional 518 shares during the last quarter. Evanson Asset Management LLC acquired a new position in UnitedHealth Group during the second quarter worth about $201,000. Parametrica Management Ltd acquired a new position in UnitedHealth Group during the second quarter worth about $201,000. Finally, Franklin Street Advisors Inc. NC acquired a new position in UnitedHealth Group during the second quarter worth about $208,000. 85.78% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Inc. (NYSE:UNH) traded down 0.24% during midday trading on Tuesday, reaching $138.16. The company’s stock had a trading volume of 2,452,575 shares. The company has a market cap of $131.58 billion, a PE ratio of 21.62 and a beta of 0.57. UnitedHealth Group Inc. has a 12 month low of $107.51 and a 12 month high of $144.48. The stock has a 50-day moving average price of $138.21 and a 200 day moving average price of $136.26.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.89 by $0.07. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The firm had revenue of $46.50 billion for the quarter, compared to analysts’ expectations of $45.05 billion. Analysts expect that UnitedHealth Group Inc. will post $7.90 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Friday, September 9th were issued a $0.625 dividend. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 dividend on an annualized basis and a dividend yield of 1.81%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 39.12%.
UNH has been the subject of a number of research analyst reports. Mizuho boosted their target price on UnitedHealth Group from $156.00 to $160.00 and gave the company a “buy” rating in a research note on Tuesday, July 19th. Credit Suisse Group AG reissued a “buy” rating and issued a $148.00 target price on shares of UnitedHealth Group in a research note on Wednesday, June 29th. Leerink Swann reissued a “buy” rating on shares of UnitedHealth Group in a research note on Friday, June 10th. Citigroup Inc. boosted their target price on UnitedHealth Group from $148.00 to $164.00 and gave the company a “buy” rating in a research note on Wednesday, July 20th. Finally, Argus upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price target on the stock in a report on Friday, July 22nd. One investment analyst has rated the stock with a hold rating, twenty-four have assigned a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $155.35.
In related news, Director Richard T. Burke sold 40,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the sale, the director now owns 2,003,550 shares of the company’s stock, valued at approximately $271,100,350.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.65% of the stock is currently owned by corporate insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.